Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 6, 2010
Pregnancy decreases rat CYP1A2 activity and expressionAlysa A Walker, Leslie Dickmann, Nina Isoherranen
Molecular Pharmacology|November 4, 2009
A comparison of the roles of peroxisome proliferator-activated receptor and retinoic acid receptor on CYP26 regulationSuzanne Tay, Leslie Dickmann, Vaishali Dixit, et al.
Drug Discovery Today|June 15, 2014
Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?Andreas Baumann, Dietrich Tuerck, Saileta Prabhu, et al.
Clinical Pharmacology and Therapeutics|April 27, 2018
Harnessing the Potential of Emerging Digital Health and Biological Sampling Technologies for Clinical Drug Development: Promise to RealityPrajakti A Kothare, Pravin R Jadhav, Pankaj Gupta, et al.
Journal of Clinical Pharmacology|September 29, 2015
Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative ColitisXiaohui Wei, Jane R Kenny, Leslie Dickmann, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 1, 2021
Quantitative systems pharmacology model-based investigation of adverse gastrointestinal events associated with prolonged treatment with PI3-kinase inhibitorsKapil Gadkar, Christina Friedrich, Vincent Hurez, et al.
Developmental Biology|November 28, 2006
Rescue of cytochrome P450 oxidoreductase (Por) mouse mutants reveals functions in vasculogenesis, brain and limb patterning linked to retinoic acid homeostasisVanessa Ribes, Diana M E Otto, Leslie Dickmann, et al.
Molecular Pharmaceutics|November 17, 2018
In Vivo Stability Profiles of Anti-factor D Molecules Support Long-Acting Delivery ApproachesKelly M Loyet, Philip E Hass, Wendy N Sandoval, et al.
Molecular Pharmaceutics|June 1, 2016
Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched FabWhitney Shatz, Philip E Hass, Mary Mathieu, et al.
Mabs|August 31, 2017
Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eyeDevin Tesar, Jacob Luoma, Emily A Wyatt, et al.
Pageof 1